The designation recognises the novelty of the technology and the potential to provide a more effective treatment option for patients with coronary artery disease.
Philips (NYSE:PHG) announced today that it launched its now FDA-cleared Zenition 90 motorized mobile C-arm system.
aXess is a restorative arteriovenous dialysis conduit which allows vascular access for hemodialysis through the creation of a new, permanent, living vessel
The potential benefits of utilizing the CORUS™ Navigation Access System to perform a navigated CORUS fusion include:
> Enhanced accuracy and precision with surgical instruments and spinal implants, e.g., CAVUX FFS-LX.
> Improved visualization of the facet joints and other anatomical structures during procedures.
> Reduced risk of complications and shorter operative time.
With the FDA 510(k) clearance of the COR-12 wireless ECG device now integrated with the SpiroSphere®, sponsors can conduct comprehensive respiratory trials with cardiac safety ECG collection on one device.
Temporary vessel occlusion a growing practice for trauma patients.
Philips (NYSE: PHG) today announced the first implant of its Duo venous stent system following FDA premarket approval.
Getinge announced today that it received FDA 510(k) clearance for its Talis +ACG (advanced clinical guidance) support software.
Medical imaging AI company receives approval for algorithm enabling opportunistic detection and triage of vertebral compression fractures.
Abbott (NYSE: ABT)+ today announced FDA clearance for two over-the-counter continuous glucose monitor (CGM) systems, Lingo and Libre Rio.